New Haven, United States
Tetricus Labs, established in 2022, is making strides in the Health Care industry by transforming how psychiatric care is delivered. With a mission encapsulated by their slogan, "Empowering patients to get better, faster," the company is led by founders Lindsay Dow, Dr. Philip Corlett, and Dr. Sean McCurdy. Their innovative approach combines breakthroughs in neuroscience with advanced machine learning technologies.
Headquartered in the United States, Tetricus Labs offers a software platform that aids leading psychiatric hospitals by efficiently managing patient referrals, ensuring optimal treatment matching, and continuously monitoring patient outcomes. This comprehensive approach aims to refine care processes, ultimately enhancing patient recovery rates.
The company secured a Seed investment on 01 September 2023, backed by Research Bridge Partners, indicating strong support for their vision and growth potential. Investors should consider Tetricus Labs a promising player in the evolving healthcare technology landscape.
